Lilly eyes $3B investment in China as it seeks approval for weight loss pill
Source: SeekingAlpha
2026-03-11 07:27:02 ET
More on Eli Lilly
- CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry
- Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade)
- Eli Lilly and Company (LLY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Hims & Hers hires former Lilly communications chief
- Lilly says GLP-1 access for some Medicare members could exceed $50 monthly cap
Read the full article on Seeking Alpha
For further details see:
Lilly eyes $3B investment in China as it seeks approval for weight loss pill
Novo Nordisk A/S
NASDAQ: NVO
NVO Trading
0.57% G/L:
$38.835 Last:
8,264,234 Volume:
$38.73 Open:
NVO Latest News
March 09, 2026 12:44:07 pm
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
NVO Stock Data
$220,548,675,000
4,194,421,000
N/A
749
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
